EIO Biomedical, a biomedical startup founded by Dr. Yair Pilpel and Dr. Rafael Miller , has a unique mission: to find a solution to prevent surgical adhesions safely and efficiently.
What is a surgical adhesion?
Adhesion means an abnormal adhesion between the intestines, between the intestine and the peritoneum, or between the intestine and the intra-abdominal organ due to various reasons (80% due to abdominal surgery). Surgical adhesions occur in high probability, and currently there is no effective prevention.
Some shocking statistics about adhesion:
- One out of every three open surgery requires reoperation due to stickiness
- One out of every five female infertility is attributed to adhesions
- One out of every 4 gynecological laparoscopy is attributed to adhesions
Solution to Surgical Adhesion
With such a tough medical problem, EIO Biomedical has proposed the most effective and simple method: medical grade anti-adhesion spray.
The spray has completed the pig body experiment and is being tested in human body and has several patents.
About EIO Biomedical
Founded by NTG3, the only medical incubator licensed by the Israel Innovation Authority, is founded by Dr. Yair Pilpel and Dr. Rafael Miller. The advisory committee includes Dr. Jeroen de Wit, honorary chairman of the European Blood Alliance, and Prof. Harry van Goor. The adhesion preventive spray developed by EIO is made with biomedical material, providing easy usage without side effects, and more economical than the commonly used bioresorbable film. EIO Biomedical is seeking strategic partner for capital investments to complete clinical trials.
1. Dr. Yair Pilpel; 2. Dr. Rafael Miller; 3. Dr. Jeroen de Wit; 4. Prof. Harry van Goor
Video Introduction
